华检医疗(01931.HK):授出3000万股奖励股份
格隆汇 12 月 15日丨华检医疗(01931.HK)宣布,于2020年12月15日,董事会决议根据在股东周年大会上由股东授予的一般授权配发及发行3000万股新股份予受托人,以供根据该计划授出奖励予若干获选雇员。
公司将安排以其资源向受托人支付总认购价15,000美元(即股份面值乘以根据一般授权将予配发及发行的新股份数目),以供受托人认购奖励股份。
公司将配发及发行予受托人的奖励股份数目占:(i)于公告日期公司已发行股本约2.27%;及(ii)经配发奖励股份后扩大的公司已发行股本约2.22%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.